Drug Combinations Show Promise in Reversing Fatty Liver Disease
Researchers at the University of Barcelona found that the existing drugs pemafibrate and telmisartan, used separately and together, significantly reduce fat buildup in animal models of fatty liver disease, suggesting a potential new treatment approach, though human trials are still needed.